» Articles » PMID: 37975182

Unreliability of Serum- or Plasma-based Assays of D-dimer or Fibrin (Fibrinogen) Degradation Product for Diagnosing Periprosthetic Joint Infection: A Prospective Parallel Study

Overview
Journal Orthop Surg
Specialty Orthopedics
Date 2023 Nov 17
PMID 37975182
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The ability of D-dimer to diagnose periprosthetic joint infection (PJI) before revision hip or knee arthroplasty is still controversial, and the differences in diagnostic ability between serum- or plasma-based assays of D-dimer and fibrin (fibrinogen) degradation product (FDP) are uncertain. The prospective parallel study was performed to determine the ability of D-dimer to diagnose PJI before revision hip or knee arthroplasty, and the differences in diagnostic ability between serum- or plasma-based assays of D-dimer and FDP.

Methods: Patients undergoing knee or hip arthroplasty at our institution were prospectively enrolled into the following groups: those without inflammatory diseases who were undergoing primary arthroplasty ("Prim" group), those with inflammatory arthritis who were undergoing primary arthroplasty ("Prim/Inflam"), those undergoing revision arthroplasty because of aseptic failure ("Rev/Asept"), or those undergoing revision arthroplasty because of PJI ("Rev/PJI"). The ability of preoperative levels of D-dimer or FDP in serum or plasma to diagnose PJI in each group was assessed using areas under receiver operating characteristic curves (AUCs) and other diagnostic performance indicators. The diagnostic performance of these assays was compared with that of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

Results: In the final analysis, Prim included 42 patients; Prim/Inflam, 40; Rev./Asept, 62; and Rev./PJI, 47. D-dimer assays led to AUCs of 0.635 in serum and 0.573 in plasma, compared to 0.593 and 0.607 for FDP. Even in combination with CRP or ESR, these assays failed to perform as well as the combination of CRP and ESR for diagnosing PJI.

Conclusion: Levels of D-dimer or FDP in serum or plasma, whether used alone or together with CRP or ESR, are unreliable for diagnosing PJI before revision arthroplasty.

Citing Articles

Are Red Blood Cell Distribution Width and Platelet Count Useful for Diagnosing Periprosthetic Joint Infection in Patients Undergoing Re-Revision Arthroplasty.

Zhang Y, Xie Q, Jiang B, Jiang W, Xu H, Zhou Z Orthop Surg. 2024; 16(12):2916-2923.

PMID: 39354799 PMC: 11608779. DOI: 10.1111/os.14219.

References
1.
Pannu T, Villa J, Manrique J, Higuera C, Riesgo A . Paradoxical Behavior of Plasma d-Dimer From Explantation to Reimplantation in a Two-Stage Revision for Periprosthetic Joint Infection. J Arthroplasty. 2022; 37(8S):S977-S982. DOI: 10.1016/j.arth.2022.02.023. View

2.
Shahi A, Kheir M, Tarabichi M, S Hosseinzadeh H, Tan T, Parvizi J . Serum D-Dimer Test Is Promising for the Diagnosis of Periprosthetic Joint Infection and Timing of Reimplantation. J Bone Joint Surg Am. 2017; 99(17):1419-1427. DOI: 10.2106/JBJS.16.01395. View

3.
Li R, Song L, Quan Q, Liu M, Chai W, Lu Q . Detecting Periprosthetic Joint Infection by Using Mass Spectrometry. J Bone Joint Surg Am. 2021; 103(20):1917-1926. DOI: 10.2106/JBJS.20.01944. View

4.
Li C, Margaryan D, Ojeda-Thies C, Perka C, Trampuz A . Meta-analysis of serum and/or plasma D-dimer in the diagnosis of periprosthetic joint infection. J Orthop Surg Res. 2020; 15(1):298. PMC: 7409706. DOI: 10.1186/s13018-020-01808-1. View

5.
Shohat N, Goswami K, Fillingham Y, Tan T, Calkins T, Della Valle C . Diagnosing Periprosthetic Joint Infection in Inflammatory Arthritis: Assumption Is the Enemy of True Understanding. J Arthroplasty. 2018; 33(11):3561-3566. DOI: 10.1016/j.arth.2018.07.016. View